Literature DB >> 348304

Mutagenicity of aclacinomycin A and daunomycin derivatives.

K Umezawa, M Sawamura, T Matsushima, T Sugimura.   

Abstract

An antitumor antibiotic aclacinomycin A, was nonmutagenic in a Salmonella test, but its derivative, N-demethylaclacinomycin A, was mutagenic. Similarly, 1-deoxypyrromycin, a hydrolysis product of aclacinomycin A, was nonmutagenic, but N-demethyl-1-deoxypyrromycin was mutagenic. Daunomycin was highly mutagenic, but N-methyldaunomycin showed only weak mutagenicity, and N-dimethyldaunomycin was nonmutagenic. The aglycones of aclacinomycin A and daunomycin were not mutagenic. Thus, the amino moiety of anthracycline glycosides is concluded to be essential for mutagenesis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 348304

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  5 in total

1.  Induction of chromosomal aberrations by the anthracycline antitumor antibiotics N,N-dimethyldaunomycin and aclacinomycin A.

Authors:  G Steinheider; J Westendorf; H Marquardt
Journal:  Experientia       Date:  1987-05-15

2.  Cellular pharmacokinetics of aclacinomycin A in cultured L1210 cells. Comparison with daunorubicin and doxorubicin.

Authors:  A Zenebergh; R Baurain; A Trouet
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

3.  Phase II trial of aclacinomycin A in acute leukemia and various solid tumors.

Authors:  J Schütte; N Niederle; S Seeber
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

4.  Induction of erythroid differentiation by the anthracycline antitumor antibiotic pyrromycin.

Authors:  G Steinheider; A Schaefer; J Westendorf; H Marquardt
Journal:  Cell Biol Toxicol       Date:  1988-03       Impact factor: 6.691

5.  Mutagenic and cytotoxic activity of doxorubicin and daunorubicin derivatives on prokaryotic and eukaryotic cells.

Authors:  N Babudri; B Pani; M Tamaro; C Monti-Bragadin; F Zunino
Journal:  Br J Cancer       Date:  1984-07       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.